Minetta C. Liu

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

7.7Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005

Top 4%

4.9DataRank

Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Papers

Driven by 37 papers — median percentile 91. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005

Top 4%

4.9DataRank

Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.07.014

N/A

0.701DataRank · unranked

22 citations

Michael B. Steele, Ianko Iankov, Susanna C. Concilio, Arun Ammayappan, Brad Bolon +8 more

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

Mayo Clinic Proceedings Innovations Quality & Outcomes(2021)10.1016/j.mayocpiqo.2021.05.003

N/A

0.430DataRank · unranked

5 citations

Minetta C. Liu, Jacob B. Allred, Lori A. Erickson, Kandelaria M. Rumilla, Matthew S. Block +5 more

Evaluation of genomic alterations in early-onset versus late-onset colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3511

Top 47%

0.381DataRank

Top 47%5 citations

Samuel Rivero-Hinojosa, Vasily N. Aushev, Adham Jurdi, Minetta C. Liu, Cathy Eng +1 more

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer

Journal of Clinical Oncology(2025)10.1200/jco-24-01875

N/A

0.319DataRank · unranked

6 citations

Karla V. Ballman, Jordan D. Campbell, Minetta C. Liu, Jennifer A. Ligibel, Mark A. Watson +12 more

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07519-z

N/A

0.174DataRank · unranked

2 citations

Anne O’Neill, Bryan P. Schneider, Todd C. Skaar, Minetta C. Liu, Caroline Lohrisch +9 more

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0539

N/A

0DataRank · unranked

84 citations

Whitney Barham, Ying Li, Henan Zhang, Joanina K. Gicobi, Jacob B. Hirdler +24 more

Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.548

N/A

0DataRank · unranked

0 citations

Jodi M. Carter, David W. Hillman, Kathleen Tenner, David M. Zahrieh, Minetta C. Liu +7 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

NAR Cancer(2022)10.1093/narcan/zcac018

N/A

0DataRank · unranked

43 citations

Roberto A. Leon‐Ferre, Jason P. Sinnwell, David Zahrieh, Vera J. Suman, Filho Otto Metzger +15 more

Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow

Frontiers in Oncology(2022)10.3389/fonc.2022.1007874

N/A

0DataRank · unranked

13 citations

Steven P. Rowe, Vered Stearns, Roisín M. Connolly, Christos Vaklavas, Minetta C. Liu +5 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1

N/A

0DataRank · unranked

2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

Clinical Management of Metastatic Hormone Receptor-Positive, HER2-negative Breast Cancer (MBC) After CDK 4/6 inhibitors: A Retrospective Single-Institution Study

Research Square(2022)10.21203/rs.3.rs-1601792/v1

N/A

0DataRank · unranked

0 citations

S. Liddell, Roberto A. Leon‐Ferre, Ciara C. O’Sullivan, Kathryn J. Ruddy, Tufia C. Haddad +6 more

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.04.008

N/A

0DataRank · unranked

175 citations

Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova +26 more

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

0DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1253629

N/A

0DataRank · unranked

18 citations

Narek Shaverdian, Jordan Eichholz, L.B. Kratochvil, Megan McCune, Yonina R. Murciano‐Goroff +27 more

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101312

N/A

0DataRank · unranked

18 citations

Julia Wulfkuhle, Denise M. Wolf, Lamorna Brown Swigart, Christina Yau, Nicholas O’Grady +22 more

Circulating tumor DNA as a marker of recurrence risk in locoregional esophagogastric cancers with pathologic complete response.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4066

N/A

0DataRank · unranked

0 citations

Brandon M. Huffman, Samuel J. Klempner, Vasily N. Aushev, Jenifer Ferguson, Shruti Sharma +5 more

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

BMC Cancer(2024)10.1186/s12885-024-12689-6

N/A

0DataRank · unranked

26 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101799

N/A

0DataRank · unranked

9 citations

Denise M. Wolf, Christina Yau, Lamorna Brown Swigart, Julie Wulfkuhle, Isela Gallagher +21 more

Monitoring Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Using Circulating Tumor DNA

Research Square(2024)10.21203/rs.3.rs-4104393/v1

N/A

0DataRank · unranked

0 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

Nature Communications(2025)10.1038/s41467-025-65432-5

N/A

0DataRank · unranked

6 citations

Nayelis A. Manon, Denise M. Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Rosalyn W. Sayaman +20 more

Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer

Research Square(2025)10.21203/rs.3.rs-6926989/v1

N/A

0DataRank · unranked

2 citations

Xiaopeng Sun, Ann Hanna, Andres A. Ocampo, Brandie C. Taylor, James R. Marshall +14 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

UNC Libraries(2025)10.17615/h225-mq92

N/A

0DataRank · unranked

0 citations

Daniel G. Stover, David Zahrieh, Matthew P. Goetz, Eric W. Klee, Lisa A. Carey +15 more

Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies

medRxiv(2025)10.1101/2025.08.23.25332468

N/A

0DataRank · unranked

0 citations

Alexander Chih-Chieh Chang, Fangyuan Chen, Shannon Puhalla, Julia Foldi, Hunter Waltermire +21 more

Liquid Biopsy: Emergence of an Alternative Cancer Detection Method

Clinical and Translational Science(2020)10.1111/cts.12776

N/A

0DataRank · unranked

9 citations

Megan L. Settell, Shaheen Kurani, Elizabeth C. Eckert, Minetta C. Liu, Alexandra J. Greenberg +1 more

Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival

medRxiv(2020)10.1101/2020.02.03.20019760

N/A

0DataRank · unranked

41 citations

Lamorna Brown Swigart, Hsin-Ta Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf +18 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25

N/A

0DataRank · unranked

0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

UNC Libraries(2020)10.17615/7w8k-g207

N/A

0DataRank · unranked

0 citations

Ann Crawford, Annick D. Van den Abbeele, Rebecca Gelman, Steven E. Come, Xiaochun Li +13 more

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

UNC Libraries(2020)10.17615/yrss-qx89

N/A

0DataRank · unranked

0 citations

Charles M. Perou, Madlyn Ferraro, Mothaffar F. Rimawi, Wing‐Keung Chiu, Antonio C. Wolff +15 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0DataRank · unranked

447 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Cancer Cell(2021)10.1016/j.ccell.2021.05.009

N/A

0DataRank · unranked

335 citations

Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace +40 more

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene(2021)10.1038/s41388-021-01711-x

N/A

0DataRank · unranked

103 citations

Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder +16 more

Minetta C. Liu

Indexed papers

Top data-sharing exemplar

Papers